IDH1 and glioma: IDH-mutated tumors were found to express less IFN-γ inducible chemokines such as CXCL10, which was further confirmed by the introduction of IDH1 mutation which decreased CXCL10 expression and reduced the number of T cells in a glioma mouse model.